Search

everythinglearnresearchcommunity

for

Search:↓

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Skin changes and high vitamin B12 levels can be early signs of cancer.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.